Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro

• Auteurs principaux: Gaofeng Qin (Auteur), Yunfang Dong (Auteur), Zhenhong Liu (Auteur), Zhuoyan Gong (Auteur), Chenyan Gao (Auteur), Mingcui Zheng (Auteur), Meijing Tian (Auteur), Yannan He (Auteur), Liqun Zhong (Auteur), Pengwen Wang (Auteur)
• Format: Livre
• Publié: BMC, 2021-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background Shen-Zhi-Ling oral liquid (SZL) is an herbal formula known for its efficacy of nourishing "heart and spleen", and is used for the treatment and prevention of middle- and early-stage dementia. This study investigated the effects of SZL on amelioration of AD, and examined...